SCHEMBL23655918

SCHEMBL23655918

COc1ccc(N(C2=CCCC=C2)c2cncc(N3CCC(F)(COCC(=O)O)CC3)n2)cc1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23655437 0.91 PTGIR (0.32) —
SCHEMBL21258676 0.87 PTGIR (0.38) —
SCHEMBL21258716 0.83 HSD17B10 (0.39) —
SCHEMBL21258660 0.82 LTC4S (0.33) —
SCHEMBL21258925 0.81 PTGIR (0.35) —
SCHEMBL21258899 0.80 PTGIR (0.39) —
SCHEMBL21258940 0.80 PTGIR (0.35) —
SCHEMBL21258877 0.79 PTGIR (0.37) —
SCHEMBL21258681 0.78 CKS1B (0.34) —
SCHEMBL21258828 0.78 PTGIR (0.37) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3851106-A1 MEDICAL USE OF PROSTACYCLIN RECEPTOR AGONIST Chinese PLA General Hospital (CN) 2021-07-21 — — EP disclosed
Send feedback